224 related articles for article (PubMed ID: 15451899)
1. Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes.
Harrison LC; Honeyman MC; Steele CE; Stone NL; Sarugeri E; Bonifacio E; Couper JJ; Colman PG
Diabetes Care; 2004 Oct; 27(10):2348-55. PubMed ID: 15451899
[TBL] [Abstract][Full Text] [Related]
2. Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes.
Fourlanos S; Perry C; Gellert SA; Martinuzzi E; Mallone R; Butler J; Colman PG; Harrison LC
Diabetes; 2011 Apr; 60(4):1237-45. PubMed ID: 21307076
[TBL] [Abstract][Full Text] [Related]
3. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes.
Keskinen P; Korhonen S; Kupila A; Veijola R; Erkkilä S; Savolainen H; Arvilommi P; Simell T; Ilonen J; Knip M; Simell O
Diabetologia; 2002 Dec; 45(12):1639-48. PubMed ID: 12488953
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.
Vardi P; Crisa L; Jackson RA
Diabetologia; 1991 Feb; 34(2):93-102. PubMed ID: 2065854
[TBL] [Abstract][Full Text] [Related]
5. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
[TBL] [Abstract][Full Text] [Related]
6. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
[TBL] [Abstract][Full Text] [Related]
7. Insulin autoantibodies as determined by competitive radiobinding assay are positively correlated with impaired beta-cell function--the Ulm-Frankfurt Population Study.
Yassin N; Seissler J; Glück M; Boehm BO; Heinze E; Pfeiffer EF; Scherbaum WA
Klin Wochenschr; 1991 Oct; 69(16):736-41. PubMed ID: 1762378
[TBL] [Abstract][Full Text] [Related]
8. Linear loss of insulin secretory capacity during the last six months preceding IDDM. No effect of antiedematous therapy with ketotifen.
Böhmer KP; Kolb H; Kuglin B; Zielasek J; Hübinger A; Lampeter EF; Weber B; Kolb-Bachofen V; Jastram HU; Bertrams J
Diabetes Care; 1994 Feb; 17(2):138-41. PubMed ID: 8137684
[TBL] [Abstract][Full Text] [Related]
9. Effect of standard nicotinamide in the prevention of type 1 diabetes in first degree relatives of persons with type 1 diabetes.
Cabrera-Rode E; Molina G; Arranz C; Vera M; González P; Suárez R; Prieto M; Padrón S; León R; Tillan J; García I; Tiberti C; Rodríguez OM; Gutiérrez A; Fernández T; Govea A; Hernández J; Chiong D; Domínguez E; Di Mario U; Díaz-Díaz O; Díaz-Horta O
Autoimmunity; 2006 Jun; 39(4):333-40. PubMed ID: 16891222
[TBL] [Abstract][Full Text] [Related]
10. [Result of 3 years of screening for preclinical phase of juvenile insulin-dependent diabetes mellitus].
Lesage C; Boitard C; Carel JC; Dauvergne M; Roger M; Chaussain JL; Bougnères PF
Arch Fr Pediatr; 1990 Dec; 47(10):709-13. PubMed ID: 2082843
[TBL] [Abstract][Full Text] [Related]
11. The natural history of pre-type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases.
Betterle C; Presotto F; Magrin L; Pedini B; Moro L; Caretto A; Zanchetta R
Diabetologia; 1994 Jan; 37(1):95-103. PubMed ID: 8150236
[TBL] [Abstract][Full Text] [Related]
12. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
[TBL] [Abstract][Full Text] [Related]
13. Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.
Lorini R; Alibrandi A; Vitali L; Klersy C; Martinetti M; Betterle C; d'Annunzio G; Bonifacio E;
Diabetes Care; 2001 Jul; 24(7):1210-6. PubMed ID: 11423504
[TBL] [Abstract][Full Text] [Related]
14. Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.
Bonifacio E; Ziegler AG; Klingensmith G; Schober E; Bingley PJ; Rottenkolber M; Theil A; Eugster A; Puff R; Peplow C; Buettner F; Lange K; Hasford J; Achenbach P;
JAMA; 2015 Apr; 313(15):1541-9. PubMed ID: 25898052
[TBL] [Abstract][Full Text] [Related]
15. Intranasally administered insulin intended for prevention of type 1 diabetes--a safety study in healthy adults.
Kupila A; Sipilä J; Keskinen P; Simell T; Knip M; Pulkki K; Simell O
Diabetes Metab Res Rev; 2003; 19(5):415-20. PubMed ID: 12951650
[TBL] [Abstract][Full Text] [Related]
16. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune response to diverse islet cell antigens in IDDM.
Durinovic-Bellò I; Hummel M; Ziegler AG
Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
[TBL] [Abstract][Full Text] [Related]
18. Reduced β-cell function in early preclinical type 1 diabetes.
Koskinen MK; Helminen O; Matomäki J; Aspholm S; Mykkänen J; Mäkinen M; Simell V; Vähä-Mäkilä M; Simell T; Ilonen J; Knip M; Veijola R; Toppari J; Simell O
Eur J Endocrinol; 2016 Mar; 174(3):251-9. PubMed ID: 26620391
[TBL] [Abstract][Full Text] [Related]
19. Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease.
Wagner R; Genovese S; Bosi E; Becker F; Bingley PJ; Bonifacio E; Miles KA; Christie MR; Bottazzo GF; Gale EA
Diabetologia; 1994 Apr; 37(4):365-71. PubMed ID: 8063036
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children.
Carel JC; Boitard C; Eisenbarth G; Bach JF; Bougnères PF
J Autoimmun; 1996 Dec; 9(6):739-45. PubMed ID: 9115576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
